CRVL Stock Overview
CorVel Corporation provides workers’ compensation, auto, liability, and health solutions for employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims.
Price History & Performance
|Historical stock prices|
|Current Share Price||US$148.06|
|52 Week High||US$213.38|
|52 Week Low||US$129.19|
|1 Month Change||-2.68%|
|3 Month Change||-10.05%|
|1 Year Change||12.60%|
|3 Year Change||70.16%|
|5 Year Change||212.03%|
|Change since IPO||14,503.18%|
Recent News & Updates
Many Would Be Envious Of CorVel's (NASDAQ:CRVL) Excellent Returns On Capital
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Here's Why I Think CorVel (NASDAQ:CRVL) Is An Interesting Stock
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
|CRVL||US Healthcare||US Market|
Return vs Industry: CRVL exceeded the US Healthcare industry which returned 2.4% over the past year.
Return vs Market: CRVL exceeded the US Market which returned -18.4% over the past year.
|CRVL Average Weekly Movement||5.0%|
|Healthcare Industry Average Movement||9.5%|
|Market Average Movement||8.1%|
|10% most volatile stocks in US Market||16.6%|
|10% least volatile stocks in US Market||3.2%|
Stable Share Price: CRVL is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: CRVL's weekly volatility (5%) has been stable over the past year.
About the Company
CorVel Corporation provides workers’ compensation, auto, liability, and health solutions for employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement services, retrospective utilization review, facility claim review, professional review, pharmacy services, directed care services, Medicare solutions, clearinghouse services, independent medical examinations, and inpatient medical bill review.
CorVel Fundamentals Summary
|CRVL fundamental statistics|
Is CRVL overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|CRVL income statement (TTM)|
|Cost of Revenue||US$494.12m|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||3.80|
|Net Profit Margin||10.28%|
How did CRVL perform over the long term?See historical performance and comparison
Is CRVL undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 1/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CRVL?
Other financial metrics that can be useful for relative valuation.
|What is CRVL's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does CRVL's PE Ratio compare to its peers?
|CRVL PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
SGFY Signify Health
LHCG LHC Group
Price-To-Earnings vs Peers: CRVL is good value based on its Price-To-Earnings Ratio (39x) compared to the peer average (58.6x).
Price to Earnings Ratio vs Industry
How does CRVL's PE Ratio compare vs other companies in the US Healthcare Industry?
Price-To-Earnings vs Industry: CRVL is expensive based on its Price-To-Earnings Ratio (39x) compared to the US Healthcare industry average (18.7x)
Price to Earnings Ratio vs Fair Ratio
What is CRVL's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||39x|
|Fair PE Ratio||n/a|
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate CRVL's Price-To-Earnings Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of CRVL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CRVL ($148.06) is trading above our estimate of fair value ($45.41)
Significantly Below Fair Value: CRVL is trading above our estimate of fair value.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate CRVL's PEG Ratio to determine if it is good value.
Discover undervalued companies
How is CorVel forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as CorVel has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Discover growth companies
- Check out CorVel's track record over time to understand how much the company has returned to shareholders and its earnings growth rate in the past.
How has CorVel performed over the past 5 years?
Past Performance Score5/6
Past Performance Score 5/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CRVL has a high level of non-cash earnings.
Growing Profit Margin: CRVL's current net profit margins (10.3%) are higher than last year (8.4%).
Past Earnings Growth Analysis
Earnings Trend: CRVL's earnings have grown by 12.5% per year over the past 5 years.
Accelerating Growth: CRVL's earnings growth over the past year (43.3%) exceeds its 5-year average (12.5% per year).
Earnings vs Industry: CRVL earnings growth over the past year (43.3%) exceeded the Healthcare industry 9.8%.
Return on Equity
High ROE: CRVL's Return on Equity (31.3%) is considered high.
Discover strong past performing companies
How is CorVel's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: CRVL's short term assets ($265.0M) exceed its short term liabilities ($171.4M).
Long Term Liabilities: CRVL's short term assets ($265.0M) exceed its long term liabilities ($31.5M).
Debt to Equity History and Analysis
Debt Level: CRVL is debt free.
Reducing Debt: CRVL has not had any debt for past 5 years.
Debt Coverage: CRVL has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: CRVL has no debt, therefore coverage of interest payments is not a concern.
Discover healthy companies
What is CorVel current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate CRVL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate CRVL's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if CRVL's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CRVL's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as CRVL has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Michael Combs (57 yo)
Mr. Michael G. Combs has been the President of CorVel Corporation since April 1, 2017 and has been its Chief Executive Officer since January 18, 2019. Mr. Combs Chief Information Officer at CorVel Corp fro...
CEO Compensation Analysis
Compensation vs Market: Michael's total compensation ($USD1.51M) is below average for companies of similar size in the US market ($USD6.88M).
Compensation vs Earnings: Michael's compensation has been consistent with company performance over the past year.
Experienced Management: CRVL's management team is seasoned and experienced (5.7 years average tenure).
Experienced Board: CRVL's board of directors are seasoned and experienced ( 28 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: CRVL insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
CorVel Corporation's employee growth, exchange listings and data sources
- Name: CorVel Corporation
- Ticker: CRVL
- Exchange: NasdaqGS
- Founded: 1987
- Industry: Health Care Services
- Sector: Healthcare
- Implied Market Cap: US$2.589b
- Shares outstanding: 17.49m
- Website: https://www.corvel.com
Number of Employees
- CorVel Corporation
- 5128 Apache Plume Road
- Suite 400
- Fort Worth
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/06/26 00:00|
|End of Day Share Price||2022/06/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.